Cerebral Embolic Protection Selection Method For TAVI Procedures
Summary
USPTO published patent application US20260096795A1 for a cerebral embolic protection selection method for TAVI procedures. The invention determines whether to deploy a CEP device by retrieving and segmenting aortic valve images to identify plaque vulnerability, then evaluating blood flow dynamics to select appropriate protection. Inventors include Holger Schmitt, Michael Grass, Christian Haase, and others.
What changed
USPTO published patent application US20260096795A1 for a cerebral embolic protection selection method for TAVI procedures. The method retrieves aortic valve images, segments them to identify the aortic valve, arch, and branching vessels, identifies plaque vulnerability, evaluates blood flow dynamics, and determines CEP device deployment suitability. Patent grants establish intellectual property rights but do not impose compliance obligations on third parties. Medical device manufacturers developing TAVI-related imaging systems or CEP devices may need to consider IP implications when designing similar technologies.
What to do next
- Monitor for patent issuance updates
Archived snapshot
Apr 12, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CEREBRAL EMBOLIC PROTECTION SELECTION METHOD FOR TAVI PROCEDURES
Application US20260096795A1 Kind: A1 Apr 09, 2026
Inventors
HOLGER SCHMITT, MICHAEL GRASS, CHRISTIAN HAASE, ARJEN VAN DER HORST, HANNES NICKISCH, MANINDRANATH VEMBAR
Abstract
Whether to deploy a cerebral embolic protection (CEP) device is determined by initially retrieving one or more image of at least part of an aorta. The image includes an aortic valve. The image is segmented to identify the aortic valve, an aortic arch, and a plurality of branching blood vessels downstream of the aortic valve. Plaque in a segment of the image at or adjacent the aortic valve is identified, and a vulnerability score associated with the plaque is generated. Dynamics of blood flow in the aortic arch and at least one of the plurality of branching blood vessels is evaluated. It is then determined whether a CEP device should be deployed at least partially based on the vulnerability score. A CEP device is selected at least partially based on the dynamics of blood flow in the aortic arch.
CPC Classifications
A61B 6/504 A61B 6/507 A61B 6/5217 A61F 2/2427 G06T 7/0012 G06V 10/26 G06V 10/82 G16H 20/40 G06T 2207/10081 G06T 2207/20081 G06T 2207/20084 G06T 2207/30104 G06V 2201/03
Filing Date
2023-09-11
Application No.
19112890
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.